Skip to main content
Full Schedule
Browse Schedule
Podium and Symposium Sessions
Browse by Date
Saturday, February 15, 2020
Sunday, February 16, 2020
Monday, February 17, 2020
Browse by Track
Browse by Title
Browse by Presenter
Posters
Browse By Title
Browse by Presenter
Browse by Time
Browse by Monitor
Faculty
Exhibitors
Sponsors
Conference App
Registration
Housing
CME Information
CME Evaluation
Login required
Login
Toggle navigation
Home
Full Schedule
Browse Schedule
Podium and Symposium Sessions
Browse by Date
Saturday, February 15, 2020
Sunday, February 16, 2020
Monday, February 17, 2020
Browse by Track
Browse by Title
Browse by Presenter
Posters
Browse By Title
Browse by Presenter
Browse by Time
Browse by Monitor
Faculty
Exhibitors
Sponsors
Conference App
Registration
Housing
CME Information
CME Evaluation
Login required
Tweets by SSO 2020 Advanced Cancer Therapies
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
A
Aigner, Karl
Medias Klinikum Burghausen
(
O P7
)
Upper Abdominal Stopflow Perfusion - The Surgical Technique Behind Locally High Drug Concentrations
Karl Aigner
Favorite
B
Baron, Ekaterina
Mercy Medical Center
(
PM P22
)
Pelvic Anastomosis without Protective Ileostomy is Safe in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Ekaterina Baron
Favorite
Bartlett, David
University of Pittsburgh School of Medicine
Sunday ePosters Monitor 2
David Bartlett
Favorite
Bennett, Sean
University of Toronto
(
O P6
)
Focused Ultrasound and Concurrent Chemotherapy for Locally Advanced Pancreatic Cancer: A Systematic Review
Sean Bennett
Favorite
Ben-Yaacov, Almog
Memorial Sloan Kettering Cancer Center
(
PM P6
)
Incomplete Cytoreductive Surgery for Appendiceal and Colorectal Peritoneal Carcinomatosis: Characteristics and Outcomes of an Overlooked Group
Almog Ben-Yaacov
Favorite
Berger, Yaniv
University of Chicago
(
PM P1
)
5-hydroxymethylation Signatures in Plasma Circulating Cell-Free DNA as Markers for Appendiceal and Colorectal Peritoneal Metastasis
Yaniv Berger
Favorite
(
PM P18
)
Interim Results of Phase II Trial for Novel Magnetic Resonance Imaging of Peritoneal Mesothelioma
Yaniv Berger
Favorite
Blumenthaler, Alisa
University of Texas MD Anderson Cancer Center
(
PM P13
)
Laparoscopic HIPEC for Low-volume Peritoneal Metastasis in Gastric and Gastroesophageal Adenocarcinoma
Alisa Blumenthaler
Favorite
Brajcich, Brian
Northwestern University
(
HPB P1
)
Risk of Performing Concurrent Procedures with Hepatic Artery Infusion
Brian Brajcich
Favorite
Broman, Kristy
Moffitt Cancer Center
(
LSM P3
)
Active Surveillance of Melanoma Patients with Sentinel Node Metastasis: An International Multi-Institution Evaluation of post-MSLT-2 Adoption and Early Outcomes
Kristy Broman
Favorite
Bruce, Adrienne
Department of Surgery, Hospital of the University of Pennsylvania
(
PM P14
)
Lymph Node Metastasis in Mucinous Appendiceal Adenocarcinoma
Adrienne Bruce
Favorite
C
Carr, Michael
Moffitt Cancer Center
(
LSM P1
)
Factors Predicting Toxicity and Response Following Isolated Limb Infusion for Melanoma: An International Multi-center Analysis
Michael Carr
Favorite
(
LSM P6
)
Institutional Percutaneous Hepatic Perfusion (PHP) for Unresectable Liver Metastases
Michael Carr
Favorite
Carter, Michela
University of Cincinnati College of Medicine
(
PM P20
)
National Trends In Cytoreductive Surgery with Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Origin: An Analysis of the National Cancer Database
Michela Carter
Favorite
Chintalapani, Shravan
University of Tennessee Health Science Center
(
PM P12
)
Impact of Histology on Survival in Colon Cancer with Peritoneal Carcinomatosis: Does it really matter?
Shravan Chintalapani
Favorite
Choi, Audrey
Loma Linda University Health
(
PM P23
)
Rate of Peritoneal Carcinomatosis in Surgically-Resected Stage II and III Colon Cancer
Audrey Choi
Favorite
Court, Karem
Houston Methodist Hospital/Houston Methodist Research Institute
(
PM P3
)
Gold Nanorod-Mediated Hyperthermia Can Improve Chemotherapeutic Efficacy in HIPEC
Karem Court
Favorite
Cunningham, Kathleen
Moffitt Cancer Center
(
LSM P7
)
The Physician Assistant's Role in Administering T-VEC for Advanced Melanoma: a Single Institution Experience
Kathleen Cunningham
Favorite
E
Eckhoff, Austin
Duke University
(
LSM P2
)
40 Minutes is Enough: Lymphoscintigraphy with Novel Agent Reduces Time Needed for Mapping
Austin Eckhoff
Favorite
Erali, Richard
Wake Forest University School of Medicine
(
O P1
)
Analysis of ERAS Protocol in Patients Undergoing Pancreaticoduodenectomy
Richard Erali
Favorite
F
Foster, Jason
University of Nebraska Medical Center
Saturday ePosters Monitor 2
Jason Foster
Favorite
Franko, Jan
MercyOne Medical Center - DSM
(
AR P2
)
Cellular Immunoprofile of Peritoneal Environment during HIPEC Procedure
Jan Franko
Favorite
(
PM P30
)
Outcomes of CS-HIPEC Among Patients with Colorectal and Appendiceal Adenocarcinoma Versus Signet-ring Cell Carcinoma
Jan Franko
Favorite
G
Gamboa, Adriana
Emory University
(
PM P5
)
Implications of Postoperative Complications on Survival after CRS/HIPEC: A Multi-Institutional Analysis of the US HIPEC Collaborative
Adriana Gamboa
Favorite
Gray, Maria
BD Surgical Reconstructive and Hemostatic Solutions
Maria Gray
Favorite
BD Surgical Reconstructive and Hemostatic Solutions
Maria Gray
Favorite
H
Hendrix, Ryan
University of Massachusetts Medical School
(
PM P7
)
Outcomes of Palliative CRS/HIPEC for Patients with Advanced Peritoneal Carcinomatosis from Appendiceal Cancer
Ryan Hendrix
Favorite
(
PM P28
)
Completeness of Cytoreduction, Regardless of Tumor Burden, is Associated with Improved Survival after CRS/HIPEC for LAMN
Ryan Hendrix
Favorite
K
Khalil, Mohamed
Medical College of Wisconsin
(
PM P2
)
Association of Muscle Quantity and Frailty on Short-term Outcomes of CRS/HIPEC in Patients with Appendiceal Cancer
Mohamed Khalil
Favorite
King, Bradley
University of California San Diego
(
PM P16
)
The Use of Predictive Modeling for Prolonged Hospital Length of Stay in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
Bradley King
Favorite
Kitai, Toshiyuki
Kishiwada City Hospital
(
PM P34
)
Influence of Older Age on the Prognosis after CRS+HIPEC for Peritoneal Carcinomatosis of Appendiceal Origin
Toshiyuki Kitai
Favorite
Kroon, Hidde
Royal Adelaide Hospital
(
LSM P1
)
Factors Predicting Toxicity and Response Following Isolated Limb Infusion for Melanoma: An International Multi-center Analysis
Hidde Kroon
Favorite
L
Levine, Edward
Wake Forest Univeristy
Saturday ePosters Monitor 1
Edward Levine
Favorite
Liu, Jason
University of Chicago Hospitals
(
O P3
)
Hospital Variation in Perioperative Outcomes of Cytoreductive Surgery for Cancer: Implications for Quality Measurement
Jason Liu
Favorite
M
Malekzadeh, Parisa
National Cancer Institute/Eastern Virginia Medical School
(
PM P33
)
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) with Cisplatin in Pediatric Patients with Peritoneal Mesothelioma: A Single Institution Experience and Long Term Follow Up
Parisa Malekzadeh
Favorite
N
Nikiforchin, Andrei
Mercy Medical Center
(
PM P4
)
Impact of Cellularity in Peritoneal Metastases on Survival in Patients with Low-Grade Appendiceal Mucinous Neoplasm (LAMN)
Andrei Nikiforchin
Favorite
P
Peters, Herman
VCU Health
(
PM P29
)
Development of a Novel Enhanced Recovery After Surgery Protocol (ERAS) For Cytoreductive Surgery & HIPEC
Herman Peters
Favorite
(
PM P32
)
A Conservative Approach To Enteral Feeding After Cytoreductive Surgery and HIPEC Leads To Improved Outcomes
Herman Peters
Favorite
Pletcher, Eric
Mount Sinai West
(
PM P8
)
Preoperative Lymphocyte-to-Monocyte Ratio Predicts Survival in HIPEC/ CRS for Colorectal and Appendiceal Adenocarcinoma
Eric Pletcher
Favorite
(
PM P31
)
Volume of Intraoperative Crystalloid Administration is Associated with Postoperative Respiratory Failure following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)
Eric Pletcher
Favorite
R
Rauwerdink, Daan
Massachusetts General Hospital
(
LSM P4
)
Adjuvant Therapy Failure Patterns in the Post-MSLT-2 era
Daan Rauwerdink
Favorite
Roife, David
Moffitt Cancer Center
(
PM P17
)
A Multi-institutional Analysis of Major Organ Resection in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Mesothelioma
David Roife
Favorite
Roncali, Emilie
University of California, Davis
(
AR P3
)
Y-90 PET Dose verification for Liver Cancer Y-90 Radioembolization Personalized Dosimetry
Emilie Roncali
Favorite
S
Shaltiel, Tali
Icahn School of Medicine at Mount Sinai
(
PM P26
)
Symptomatic Presentation Harbors Worse Prognosis With Low Grade Appendiceal Mucinous Neoplasm
Tali Shaltiel
Favorite
Shen, Ding
School of Biomedical and Pharmaceutical Sciences
(
HPB P3
)
Analysis of Cholyglycine Acid as a Biomarker for the Early Diagnosis of Liver Disease
Ding Shen
Favorite
Shin, Paul
Memorial Sloan Kettering Cancer Center
(
HPB P4
)
Clinical Significance of SMAD4 Mutation Status in Patients with Resected Colorectal Liver Metastases
Paul Shin
Favorite
Sipok, Arkadii
Inova Fairfax Hospital
(
PM P15
)
Prognostic Factors And Outcomes Of Non-Invasive Mucinous Appendiceal Neoplasms With And Without Peritoneal Spread
Arkadii Sipok
Favorite
Spiliotis, John
Athens Medical Center
(
PM P19
)
Mitomycin C versus Oxaliplatin During Cytoreductive Surgery and HIPEC for Peritoneal Metastases Secondary to Colorectal Carcinoma: A Retrospective Analysis
John Spiliotis
Favorite
Stein, Matthew
UTHSC/West Cancer Center
(
PM P9
)
Site-specific Molecular Comparison Between Primary Gastric (GC) and Gastroesophageal Junction (GEJ) Cancer Emphasizing Peritoneal Metastases (PM)
Matthew Stein
Favorite
Strong, Erin
Medical College of Wisconsin
(
O P5
)
Percutaneous Cryoablation: A Novel First-Line Therapy for Extra-Abdominal Desmoid Tumors
Erin Strong
Favorite
Sucandy MD FACS, Iswanto
AdventHealth Tampa
(
HPB P2
)
Robotic Major Hepatectomy: An Institutional Eexperience and Clinical Outcomes
Iswanto Sucandy MD FACS
Favorite
Suchar, Adam
University of North Carolina Chapel Hill
(
PM P27
)
Anesthesia and Pain Management of Pediatric Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Desmoplastic Small Round Cell Tumors Utilizing a Tunneled Thoracic Epidural; Initiation of a New Pediatric HIPEC Program
Adam Suchar
Favorite
T
Turaga, Kiran
University of Chicago
Sunday ePosters Monitor 1
Kiran Turaga
Favorite
Turgeon, Michael
Winship Cancer Institute, Emory University
(
PM P10
)
The Intersection of Age and Tumor Biology with Postoperative Outcomes in Patients After Cytoreductive Surgery and HIPEC
Michael Turgeon
Favorite
V
Violette, Caroline
Emory University School of Medicine
(
O P2
)
Cytoreductive Surgery, Hyperthermic Intraperitoneal Chemotherapy and Subsequent Fertility: Should We Be Doing More?
Caroline Violette
Favorite
W
White, Michael
MD Anderson Cancer Center
(
PM P36
)
Should Ascites be a Contraindication to Laparoscopic HIPEC in Gastric Cancer?
Michael White
Favorite
Y
Yadegarynia, Sina
University of Miami Miller School of Medicine
(
PM P24
)
Survival Benefits of Redo Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients with Recurrent Peritoneal Carcinomatosis
Sina Yadegarynia
Favorite
(
PM P35
)
Is Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Safe in Septuagenarians?
Sina Yadegarynia
Favorite
(
PM P37
)
The Impact of Postoperative Peritoneal Carcinomatosis Index on Survival of Patients with Peritoneal Surface Malignancy from Appendiceal Origin after CRS/HIPEC
Sina Yadegarynia
Favorite
Z
Zambrano-Vera, Katherin
Mercy Medical Center
(
PM P21
)
Outcomes in Elderly Ovarian Cancer Patients Treated with CytoreductiveSurgery plus Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)
Katherin Zambrano-Vera
Favorite
Zhang, Chunmeng
University of Nebraska Medical Center
(
LSM P5
)
Exploring Head and Neck Melanoma Sentinel Lymph Node Outcome Compliance with Multicenter Selective Lymphadenectomy Trials Predicted Outcome
Chunmeng Zhang
Favorite
(
PM P11
)
Carboplatin Hyperthermic Intraperitoneal Chemotherapy is Safe and Efficacious in Recurrent and Advanced Ovarian Cancer
Chunmeng Zhang
Favorite
Back to Top
